The model justifies its answers in detail based on the guidelines. The study is published in the journal ESMO Real World Data ...

The results of the open-label DESTINY-Breast12 trial – reported at the ESMO cancer congress in Barcelona ... that – at the moment – treatment guidelines do not recommend screening patients ...

Despite this being a month packed with reminders to schedule your screening, the guidelines on when you should begin making mammograms a part of your annual medical checklist are incredibly unclear.

Among the many impactful sessions, a symposium titled ‘Incorporating Novel Treatment Insights for Estrogen Receptor-Positive (ER+) Early Breast Cancer Patients’ garnered particular attention.

Now, new data from the POD1UM-303 study reported at ESMO suggests the company could resurrect the SCAC indication and move Zynyz into the first-line setting to boot. Given in combination with ...

Seeing the disappointing post ESMO selloff (across a number of companies ... The impact of AbbVie's Elahere is misrepresented in my eyes, as NCCN guidelines recommend its use with Avastin in ...

Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to ...

esmo group has launched its latest product—the Apollo Quad Handler. Designed to bridge the gap between the engineering and ...

Please see the dropdown below for our guidelines. As you prepare your manuscript for submission to an ESA publication, you should review our “Manuscript Preparation Guide” for formatting requirements ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

(Image Credits: Pexels) The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated this month to recommend ribociclib (Kisqali) as a Category 1 preferred ...